Literature DB >> 21365795

The case for a worldwide ban on smoking in public places.

Daniel Menzies1.   

Abstract

PURPOSE OF REVIEW: Second-hand smoke (SHS) is a major cause of morbidity and mortality on a global scale. Governments have increasingly sought to mitigate the effects of SHS by introducing legislation that restricts tobacco consumption in public places. There is emerging evidence that such legislation leads to direct and indirect health benefits. RECENT
FINDINGS: Exposure to SHS is now shown to be associated with development of cardiovascular disease, and poorer health outcomes in patients with established chronic obstructive pulmonary disease. Childhood (including in-utero) exposure to SHS has recently been linked with increased risk of cleft palate, demonstrable signs of atherosclerosis, and the development of emphysema and lung cancer in adulthood. Comprehensive bans on smoking in public lead to a reduction in overall exposure to SHS for both adults and children and have also been shown to immediately attenuate the incidence of myocardial infarction and paediatric hospital attendances with acute asthma.
SUMMARY: Banning smoking in public places is an effective tool for reducing tobacco-related morbidity across a multiplicity of diseases. Countries that have not already done so should introduce legislation to enforce effective legislation that prohibits smoking in public places.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21365795     DOI: 10.1097/mcp.0b013e328341ce98

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  12 in total

1.  Secondhand smoke exposure and smoking behavior among young adult bar patrons.

Authors:  Sara Kalkhoran; Torsten B Neilands; Pamela M Ling
Journal:  Am J Public Health       Date:  2013-09-12       Impact factor: 9.308

2.  Integrating genetic studies of nicotine addiction into public health practice: stakeholder views on challenges, barriers and opportunities.

Authors:  M J Dingel; A D Hicks; M E Robinson; B A Koenig
Journal:  Public Health Genomics       Date:  2011-07-09       Impact factor: 2.000

3.  Linking empirical estimates of body burden of environmental chemicals and wellness using NHANES data.

Authors:  Chris Gennings; Rhonda Ellis; Joseph K Ritter
Journal:  Environ Int       Date:  2011-11-01       Impact factor: 9.621

4.  Thirdhand smoke component can exacerbate a mouse asthma model through mast cells.

Authors:  Mang Yu; Kaori Mukai; Mindy Tsai; Stephen J Galli
Journal:  J Allergy Clin Immunol       Date:  2018-04-18       Impact factor: 10.793

5.  Effects of second hand smoke on airway secretion and mucociliary clearance.

Authors:  Yanyan Liu; Y Peter Di
Journal:  Front Physiol       Date:  2012-08-28       Impact factor: 4.566

6.  Is there a regulatory role of immunoglobulins on tissue forming cells relevant in chronic inflammatory lung diseases?

Authors:  Michael Roth
Journal:  J Allergy (Cairo)       Date:  2011-11-02

7.  Second hand smoke and COPD: lessons from animal studies.

Authors:  Michael T Borchers; Adelheid Kratzer; Laimute Taraseviciene-Stewart
Journal:  Front Physiol       Date:  2014-04-10       Impact factor: 4.566

8.  Sex-specific lung functional changes in adult mice exposed only to second-hand smoke in utero.

Authors:  Alexandra Noël; Rui Xiao; Zakia Perveen; Hasan Zaman; Viviana Le Donne; Arthur Penn
Journal:  Respir Res       Date:  2017-06-27

9.  Environmental Tobacco Smoke in Occupational Settings: Effect and Susceptibility Biomarkers in Workers From Lisbon Restaurants and Bars.

Authors:  Nádia Vital; Susana Antunes; Henriqueta Louro; Fátima Vaz; Tânia Simões; Deborah Penque; Maria João Silva
Journal:  Front Public Health       Date:  2021-06-04

Review 10.  Passive smoking in the etiology of non-syndromic orofacial clefts: a systematic review and meta-analysis.

Authors:  Heba J Sabbagh; Mona Hassan Ahmed Hassan; Nicola P T Innes; Heba M Elkodary; Julian Little; Peter A Mossey
Journal:  PLoS One       Date:  2015-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.